Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret)

NCT01802892 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Transplantation, Stem Cell

Interventions

DRUG: Ronacaleret 100 mg
DRUG: Ronacaleret 400 mg
DRUG: Plerixafor

Sponsor

GlaxoSmithKline